Albemarle Corporation Profile Avatar - Palmy Investing

Albemarle Corporation

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hy…
Chemicals - Specialty
US, Charlotte [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
24.13 31.57 34.06 33.15 32.92 31.52 32.78 36.25 36.13 36.07 35.04 31.80 29.99 42.00 12.49
Profit Margin
8.89 13.70 15.21 11.35 15.79 5.45 9.17 24.04 1.79 20.55 14.86 12.01 3.72 27.91 16.36
Operating Margin
9.29 17.56 20.49 14.79 22.28 11.09 12.12 21.46 19.13 27.01 18.56 16.17 -3.03 33.74 2.51
EPS Growth
-8.45 81.54 36.16 -27.59 41.26 -65.72 78.11 90.37 -91.45 1,206.12 -21.41 -29.82 -69.69 1,529.91 -23.11
Return on Assets (ROA)
6.44 10.55 13.62 9.06 11.53 2.55 3.48 7.89 0.71 9.15 5.41 3.60 1.13 13.22 8.61
Return on Equity (ROE)
14.79 22.86 27.42 16.99 25.39 9.81 10.29 16.96 1.49 19.34 13.56 8.80 2.20 25.59 16.72
Return on Invested Capital (ROIC)
9.63 13.91 30.86 12.50 16.15 5.77 5.72 7.58 0.36 14.09 8.02 5.51 -0.98 18.51 -1.33
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
29.32 28.06 23.84 20.34 30.10 56.18 40.06 29.03 23.71 22.49 31.17 34.18 21.82 20.81 22.40
Debt/Equity
67.41 60.80 47.99 38.14 66.30 215.83 118.36 62.43 50.00 47.56 78.16 83.69 42.56 40.30 43.49
Debt/EBITDA
254.61 78.53 42.98 42.69 98.73 143.05 577.32 19.30 124.54 180.61 294.95 416.34 1,276.73 59.95 509.80
Debt/Capitalization
40.27 37.81 32.43 27.61 39.87 68.34 54.20 38.44 33.33 32.23 43.87 45.56 29.86 28.72 30.31
Interest Debt per Share USD
9.15 9.70 8.85 8.21 13.24 37.81 35.84 21.66 17.61 16.21 29.55 34.26 21.20 28.52 36.50
Debt Growth
-12.82 5.93 -11.30 -8.43 54.28 171.97 31.28 -38.49 -22.45 -7.19 80.24 16.23 -32.97 34.37 34.00
Liquidity
Current Ratio
287.95 370.20 337.91 365.53 339.84 293.79 113.26 290.03 206.30 168.90 157.92 122.44 107.13 189.23 146.52
Quick Ratio
178.00 248.32 214.61 240.70 228.14 258.56 53.82 246.72 146.28 105.92 91.79 74.34 56.68 104.92 76.54
Cash Ratio
86.15 145.44 117.01 124.07 109.37 218.42 13.22 199.08 94.70 46.93 43.51 41.44 23.44 54.69 24.99
Operating Cash Flow Ratio
100 - - 100 100 - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
437.84 415.42 438.46 428.69 402.48 467.32 482.47 379.03 330.98 308.00 303.21 284.45 286.62 204.50 389.41
Receivables Turnover
609.14 630.64 732.69 611.42 504.84 534.58 556.23 492.94 495.97 483.60 527.70 527.82 534.09 531.68 524.04
Payables Turnover
893.51 922.95 1,025.60 1,061.76 904.35 722.77 800.76 605.46 468.78 412.94 406.11 441.63 359.57 206.90 403.07
Asset Turnover
72.36 77.01 89.55 79.87 72.99 46.82 37.98 32.80 39.63 44.51 36.40 29.94 30.33 47.36 52.64
Coverage
Interest Coverage
757.73 1,624.75 1,564.49 1,238.30 1,847.05 655.97 333.35 881.47 509.54 1,739.41 1,154.56 691.79 -164.09 2,008.62 127.73
Asset Coverage
200 200 300 400 200 100 100 200 300 300 200 200 300 300 300
Cash Flow Coverage (CFGR)
44.11 38.48 59.92 69.89 40.12 16.79 9.36 30.95 16.54 32.03 23.41 22.37 14.38 59.30 32.38
EBITDA Coverage
800 1,600 1,800 1,500 1,900 700 400 700 400 1,200 1,400 900 200 2,300 300
Dividend Coverage
-300 -600 -700 -400 -500 -100 -200 -400 - - -400 -300 -200 - - -1,100 -800
Time Interest Earned (TIE)
100 200 200 200 300 100 100 200 200 200 200 200 200 500 100
Market Prospects
Dividend Yield
1.69 0.97 1.24 1.25 1.47 1.78 1.92 1.40 0.99 1.73 1.97 1.03 0.66 0.73 1.10
Earnings Yield
5.36 6.35 9.36 5.62 7.77 2.82 5.38 6.65 0.39 8.30 6.89 2.39 0.46 8.04 9.28
Price/Earnings (P/E)
1,865.97 1,574.79 1,068.76 1,778.42 1,286.28 3,549.45 1,859.42 1,502.87 25,861.06 1,204.86 1,451.26 4,177.20 21,896.75 1,243.29 1,077.23
Price/Book (P/B)
276.05 360.00 293.02 302.16 326.58 348.08 191.35 254.90 386.03 233.07 196.80 367.75 481.40 318.17 180.09
Price/Sales (P/S)
165.97 215.76 162.52 201.81 203.12 193.49 170.55 361.33 461.75 247.60 215.59 501.66 813.72 346.97 176.25
Price/Cash Flow (P/CF)
928.33 1,538.72 1,018.99 1,133.55 1,227.78 960.60 1,726.50 1,319.00 4,666.37 1,530.03 1,075.73 1,964.72 7,866.26 1,331.27 1,278.93
End of ALB's Analysis
CIK: 915913 CUSIP: 012653101 ISIN: US0126531013 LEI: - UEI: -
Secondary Listings